{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T01:26:12Z","timestamp":1790558772518,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.7759\/cureus.91948","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:32:07Z","timestamp":1757485927000},"source":"Crossref","is-referenced-by-count":1,"title":["Influence of Glutathione S-transferase Mu 1 (GSTM1), Glutathione S-transferase Theta 1 (GSTT1), and N-acetyltransferase 2 (NAT2) Variants on Bladder Cancer Progression and Recurrence Rating: A Bosnian and Herzegovinian Case-Control Study"],"prefix":"10.7759","author":[{"given":"Osman","family":"Hadziosmanovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kulovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Valjevac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almir","family":"Fajki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabela","family":"Uzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201800079","article-title":"Cruciferous vegetables, isothiocyanates, and bladder cancer prevention","volume":"62","author":"Abbaoui B","year":"2018","unstructured":"Abbaoui B, Lucas CR, Riedl KM, Clinton SK, Mortazavi A. Cruciferous vegetables, isothiocyanates, and bladder cancer prevention. Mol Nutr Food Res. 2018, 62:e1800079. 10.1002\/mnfr.201800079","journal-title":"Mol Nutr Food Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(98)00183-9","article-title":"Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk","volume":"132","author":"Katoh T","year":"1998","unstructured":"Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T. Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett. 1998, 132:147-52. 10.1016\/s0304-3835(98)00183-9","journal-title":"Cancer Lett"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1074570","article-title":"Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk: an updated meta-analysis","volume":"13","author":"Ye J","year":"2022","unstructured":"Ye J, Mu YY, Wang J, He XF. Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk: an updated meta-analysis. Front Genet. 2022, 13:1074570. 10.3389\/fgene.2022.1074570","journal-title":"Front Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(05)01001-3","article-title":"Nomenclature for mammalian soluble glutathione transferases","volume":"401","author":"Mannervik B","year":"2005","unstructured":"Mannervik B, Board PG, Hayes JD, Listowsky I, Pearson WR. Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol. 2005, 401:1-8. 10.1016\/S0076-6879(05)01001-3","journal-title":"Methods Enzymol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5014-1","article-title":"Association of glutathione S-transferase gene polymorphism with bladder cancer susceptibility","volume":"18","author":"Zhou T","year":"2018","unstructured":"Zhou T, Li HY, Xie WJ, Zhong Z, Zhong H, Lin ZJ. Association of glutathione S-transferase gene polymorphism with bladder cancer susceptibility. BMC Cancer. 2018, 18:1088. 10.1186\/s12885-018-5014-1","journal-title":"BMC Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-020-06107-w","article-title":"Effects of GSTT1 and GSTM1 polymorphisms in glutathione levels and breast cancer development in Brazilian patients","volume":"48","author":"Pacholak LM","year":"2021","unstructured":"Pacholak LM, Kern R, de Oliveira ST, et al.. Effects of GSTT1 and GSTM1 polymorphisms in glutathione levels and breast cancer development in Brazilian patients. Mol Biol Rep. 2021, 48:33-40. 10.1007\/s11033-020-06107-w","journal-title":"Mol Biol Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3233\/DMA-2010-0729","article-title":"GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer","volume":"29","author":"Ha YS","year":"2010","unstructured":"Ha YS, Yan C, Lym MS, et al.. GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer. Dis Markers. 2010, 29:81-7. 10.3233\/DMA-2010-0729","journal-title":"Dis Markers"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.22159\/ajpcr.2018.v11i5.25673","article-title":"Polymorphic deletions of glutathione S-transferases M1, T1 and bladder cancer risk in Algerian population","volume":"11","author":"Hireche A","year":"2018","unstructured":"Hireche A, Kherouatou NC, Ribouh A, Abadi N, Shi MJ, Satta D. Polymorphic deletions of glutathione S-transferases M1, T1 and bladder cancer risk in Algerian population. Asian J Pharm Clin Res. 2018, 11:458-62. 10.22159\/ajpcr.2018.v11i5.25673","journal-title":"Asian J Pharm Clin Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-014-1847-7","article-title":"N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis","volume":"35","author":"Yu J","year":"2014","unstructured":"Yu J, Deng Y, Chen JP. N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis. Tumour Biol. 2014, 35:6861-5. 10.1007\/s13277-014-1847-7","journal-title":"Tumour Biol"},{"key":"ref10","article-title":"The relationship between passive smoking, breast cancer risk and N-acetyltransferase 2 (NAT2) [Article in Hebrew]","volume":"153","author":"Avraham Z","year":"2014","unstructured":"Avraham Z, Baron-Epel O, Boker LK. The relationship between passive smoking, breast cancer risk and N-acetyltransferase 2 (NAT2) [Article in Hebrew]. Harefuah. 2014, 153:171-5, 238.","journal-title":"Harefuah"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2022.2040642","article-title":"N-acetyltransferase 2, glutathione S-transferase gene polymorphisms and susceptibility to hepatocellular carcinoma in an Algerian population","volume":"52","author":"Chorfi L","year":"2022","unstructured":"Chorfi L, Fercha A, Derouiche F, Sebihi FZ, Houhou D, Chorfi K, Bendjemana K. N-acetyltransferase 2, glutathione S-transferase gene polymorphisms and susceptibility to hepatocellular carcinoma in an Algerian population. Xenobiotica. 2022, 52:99-104. 10.1080\/00498254.2022.2040642","journal-title":"Xenobiotica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.88","article-title":"Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations","volume":"12","author":"Mortensen HM","year":"2011","unstructured":"Mortensen HM, Froment A, Lema G, et al.. Characterization of genetic variation and natural selection at the arylamine N-acetyltransferase genes in global human populations. Pharmacogenomics. 2011, 12:1545-58. 10.2217\/pgs.11.88","journal-title":"Pharmacogenomics"},{"key":"ref13","article-title":"Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms","volume":"9","author":"Hein DW","year":"2000","unstructured":"Hein DW, Doll MA, Fretland AJ, et al.. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev. 2000, 9:29-42.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1081\/dmr-100101932","article-title":"Arylamine N-acetyltransferase activity in man","volume":"31","author":"Cascorbi I","year":"1999","unstructured":"Cascorbi I, Brockm\u00f6ller J, Mrozikiewicz PM, M\u00fcller A, Roots I. Arylamine N-acetyltransferase activity in man. Drug Metab Rev. 1999, 31:489-502. 10.1081\/dmr-100101932","journal-title":"Drug Metab Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.144924","article-title":"N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: an updated meta-analysis based on 54 case-control studies","volume":"757","author":"Song Y","year":"2020","unstructured":"Song Y, Qi X, Liu X. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: an updated meta-analysis based on 54 case-control studies. Gene. 2020, 757:144924. 10.1016\/j.gene.2020.144924","journal-title":"Gene"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2019.1618511","article-title":"N-acetyltransferase: the practical consequences of polymorphic activity in man","volume":"50","author":"Mitchell SC","year":"2020","unstructured":"Mitchell SC. N-acetyltransferase: the practical consequences of polymorphic activity in man. Xenobiotica. 2020, 50:77-91. 10.1080\/00498254.2019.1618511","journal-title":"Xenobiotica"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dym043","article-title":"Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study","volume":"36","author":"Lubin JH","year":"2007","unstructured":"Lubin JH, Kogevinas M, Silverman D, et al.. Evidence for an intensity-dependent interaction of NAT2 acetylation genotype and cigarette smoking in the Spanish Bladder Cancer Study. Int J Epidemiol. 2007, 36:236-41. 10.1093\/ije\/dym043","journal-title":"Int J Epidemiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004417","article-title":"rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: a systematic review and meta-analysis","volume":"95","author":"Ma C","year":"2016","unstructured":"Ma C, Gu L, Yang M, et al.. rs1495741 as a tag single nucleotide polymorphism of N-acetyltransferase 2 acetylator phenotype associates bladder cancer risk and interacts with smoking: a systematic review and meta-analysis. Medicine (Baltimore). 2016, 95:e4417. 10.1097\/MD.0000000000004417","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgq223","article-title":"GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis","volume":"32","author":"Moore LE","year":"2011","unstructured":"Moore LE, Baris DR, Figueroa JD, et al.. GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis. 2011, 32:182-9. 10.1093\/carcin\/bgq223","journal-title":"Carcinogenesis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2011.11.027","article-title":"Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility","volume":"31","author":"Safarinejad MR","year":"2013","unstructured":"Safarinejad MR, Safarinejad S, Shafiei N, Safarinejad S. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Urol Oncol. 2013, 31:1193-203. 10.1016\/j.urolonc.2011.11.027","journal-title":"Urol Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-239","article-title":"Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women","volume":"6","author":"McGrath M","year":"2006","unstructured":"McGrath M, Michaud D, De Vivo I. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer. 2006, 6:239. 10.1186\/1471-2407-6-239","journal-title":"BMC Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13702","article-title":"GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: evidence from updated meta-analysis","volume":"8","author":"Yu C","year":"2017","unstructured":"Yu C, Hequn C, Longfei L, et al.. GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: evidence from updated meta-analysis. Oncotarget. 2017, 8:3246-58. 10.18632\/oncotarget.13702","journal-title":"Oncotarget"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004900","article-title":"The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis","volume":"95","author":"Yu Y","year":"2016","unstructured":"Yu Y, Li X, Liang C, et al.. The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Medicine (Baltimore). 2016, 95:e4900. 10.1097\/MD.0000000000004900","journal-title":"Medicine (Baltimore)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)01892-7","article-title":"GSTT1-null genotype is a protective factor against bladder cancer","volume":"60","author":"Kim WJ","year":"2002","unstructured":"Kim WJ, Kim H, Kim CH, Lee MS, Oh BR, Lee HM, Katoh T. GSTT1-null genotype is a protective factor against bladder cancer. Urology. 2002, 60:913-8. 10.1016\/s0090-4295(02)01892-7","journal-title":"Urology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2004.04.001","article-title":"Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India","volume":"156","author":"Sobti RC","year":"2005","unstructured":"Sobti RC, Al-Badran AI, Sharma S, Sharma SK, Krishan A, Mohan H. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India. Cancer Genet Cytogenet. 2005, 156:68-73. 10.1016\/j.cancergencyto.2004.04.001","journal-title":"Cancer Genet Cytogenet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2005.01.005","article-title":"Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder","volume":"65","author":"Simic T","year":"2005","unstructured":"Simic T, Mimic-Oka J, Savic-Radojevic A, et al.. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder. Urology. 2005, 65:1035-40. 10.1016\/j.urology.2005.01.005","journal-title":"Urology"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2022.0090","article-title":"Worldwide systematic review of GSTM1 and GSTT1 null genotypes by continent, ethnicity, and therapeutic area","volume":"26","author":"Nakanishi G","year":"2022","unstructured":"Nakanishi G, Pita-Oliveira M, Bertagnolli LS, et al.. Worldwide systematic review of GSTM1 and GSTT1 null genotypes by continent, ethnicity, and therapeutic area. OMICS. 2022, 26:528-41. 10.1089\/omi.2022.0090","journal-title":"OMICS"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/jvim.15504","article-title":"Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma","volume":"33","author":"Luethcke KR","year":"2019","unstructured":"Luethcke KR, Ekena J, Chun R, Trepanier LA. Glutathione S-transferase theta genotypes and environmental exposures in the risk of canine transitional cell carcinoma. J Vet Intern Med. 2019, 33:1414-22. 10.1111\/jvim.15504","journal-title":"J Vet Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-1306","article-title":"GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt","volume":"20","author":"Goerlitz D","year":"2011","unstructured":"Goerlitz D, El Daly M, Abdel-Hamid M, et al.. GSTM1, GSTT1 null variants, and GPX1 single nucleotide polymorphism are not associated with bladder cancer risk in Egypt. Cancer Epidemiol Biomarkers Prev. 2011, 20:1552-4. 10.1158\/1055-9965.EPI-10-1306","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2021.22.8.2479","article-title":"Modifying effect of smoking on GSTM1 and NAT2 in relation to the risk of bladder cancer in Mongolian population: a case-control study","volume":"22","author":"Avirmed S","year":"2021","unstructured":"Avirmed S, Khuanbai Y, Sanjaajamts A, Selenge B, Dagvadorj BU, Ohashi M. Modifying effect of smoking on GSTM1 and NAT2 in relation to the risk of bladder cancer in Mongolian population: a case-control study. Asian Pac J Cancer Prev. 2021, 22:2479-85. 10.31557\/APJCP.2021.22.8.2479","journal-title":"Asian Pac J Cancer Prev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/406410-influence-of-glutathione-s-transferase-mu-1-gstm1-glutathione-s-transferase-theta-1-gstt1-and-n-acetyltransferase-2-nat2-variants-on-bladder-cancer-progression-and-recurrence-rating-a-bosnian-and-herzegovinian-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:32:09Z","timestamp":1757485929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/406410-influence-of-glutathione-s-transferase-mu-1-gstm1-glutathione-s-transferase-theta-1-gstt1-and-n-acetyltransferase-2-nat2-variants-on-bladder-cancer-progression-and-recurrence-rating-a-bosnian-and-herzegovinian-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.91948","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,9]]}}}